ReviewJournal of hematology & oncology2017

Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.

Prabhsimranjot Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.